Literature DB >> 2293967

Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome.

C Richard1, F Lemonnier, M Thibault, M Couturier, P Auzepy.   

Abstract

Vitamin E (Vit E) is an important component of the lung's defense against oxidant injury. The aim of this study was to determine a) if adult respiratory distress syndrome (ARDS) was associated with a decrease in Vit E plasma level linked to an enhancement of plasma lipoperoxidation, and b) if this Vit E deficiency might be explained by malnutrition and/or a consumption defect. Vit E, lipoperoxides (LP), total lipids, and fatty acid plasma levels were measured in 12 patients with ARDS (PaO2 less than or equal to 60 Torr with FIO2 0.6 on mechanical ventilation). At the onset of ARDS (T0), the decrease in Vit E plasma level was significant (p less than .001) 7.73 +/- 0.54 (n = 12) vs. 11.46 +/- 0.55 mg/L (n = 7) in the control group (healthy subjects breathing room air). A significant (p less than .05) increase in LP was simultaneously observed (4.12 +/- 0.35 [n = 12] vs. 2.94 +/- 0.30 nmol/ml [n = 17]) in the control group. At T0, LP were inversely correlated with Vit E plasma levels (r = .78, p less than .01). Vit E deficiency was associated with low levels of total plasma lipids (3.68 +/- 0.25 g/L) and plasma cholesterol (0.97 +/- 0.07 g/L). Thus, the Vit E/total lipids ratio (2.18 +/- 0.17 mg/g) was always above the accepted normal limit value for this ratio (0.8 mg/g).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293967     DOI: 10.1097/00003246-199001000-00002

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  20 in total

Review 1.  Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels.

Authors:  M P Fink; T W Evans
Journal:  Intensive Care Med       Date:  2002-02-08       Impact factor: 17.440

Review 2.  The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.

Authors:  M Messent; M J Griffiths
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

3.  Vitamin E down-modulates mitogen-activated protein kinases, nuclear factor-kappaB and inflammatory responses in lung epithelial cells.

Authors:  B Ekstrand-Hammarström; C Osterlund; B Lilliehöök; A Bucht
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

4.  Oxidative stress in rodent closed duodenal loop pancreatitis.

Authors:  J Peralta; C Reides; S García; S Llesuy; G Pargament; M C Carreras; S Catz; J J Poderoso
Journal:  Int J Pancreatol       Date:  1996-02

5.  Plasma lipid peroxides and antioxidants in human septic shock.

Authors:  A C Ogilvie; A B Groeneveld; J P Straub; L G Thijs
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

6.  Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients.

Authors:  Avery B Nathens; Margaret J Neff; Gregory J Jurkovich; Patricia Klotz; Katherine Farver; John T Ruzinski; Frank Radella; Iris Garcia; Ronald V Maier
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

7.  Elevated serum bleomycin-detectable iron concentrations in patients with sepsis syndrome.

Authors:  H F Galley; N R Webster
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

8.  Characteristics of neutrophil influx in rat lungs following fecal peritonitis.

Authors:  J G Peralta; M L Barnard; J F Turrens
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

9.  Ferritin and desferrioxamine attenuate xanthine oxidase-dependent leak in isolated perfused rat lungs.

Authors:  Brooks M Hybertson; Kevin G Connelly; Raquel T Buser; John E Repine
Journal:  Inflammation       Date:  2002-08       Impact factor: 4.092

10.  Lung vitamin E transport processes are affected by both age and environmental oxidants in mice.

Authors:  Giuseppe Valacchi; Vihas T Vasu; Wallace Yokohama; Ana M Corbacho; Anh Phung; Yunsook Lim; Hnin Hnin Aung; Carroll E Cross; Paul A Davis
Journal:  Toxicol Appl Pharmacol       Date:  2007-05-01       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.